Skip to content

Five things to know about this week’s COVID-19 report

Some numbers starting to trend back up again.
covid 19 graph Thomas Faull Getty
Some numbers are starting to go the wrong direction again.

REGINA — The Saskatchewan Ministry of Health's weekly COVID-19 integrated epidemiology (epi) report was issued Thursday, June 16 for the period ending June 11, and there are a few things you should know.

 

Case numbers going up for the first time in weeks

A total of 394 new cases were confirmed reflecting 24 laboratory-confirmed cases per 100,000 population, higher than the 285 new cases in the previous week.

 

Lab tests numbers are about even while test positivity goes up 

A total of 5,880 laboratory tests were performed in Saskatchewan reflecting 4.9 tests performed per 1,000 population. The number of tests was nearly identical to the number of tests in the previous week, at 5,888.

The weekly test positivity of 6.5 per cent, is an increase from the previous week’s 4.6 per cent.

 

Hospitalizations down again  

Total COVID hospitalized are 165, down 22 from the previous week.

The total COVID adult ICU/ICU surge is six, down four.

Average daily admissions over the past seven days are 12, which is down three.

Total COVID related illness is 51, down five.

Total incidental COVID infection is 106, down 12.

Total patients under investigation are eight, down five.

 

Death numbers updated to include missing data

There were 17 newly reported COVID-19 deaths: two within the week, and another 15 occurred earlier (September 28, 2021 to June 4, 2022) but were reported this week, higher compared to the previous week (10).  

A regular audit process, which has been used throughout the pandemic, discovered the missing information and these were included in this week’s case count.

 

Evusheld™ Now Available

The province has announced that Evusheld™ is available in Saskatchewan for pre-exposure prophylaxis of COVID-19 in adults and adolescents (12 years of age or older), weighing at least 40 kilograms, who have not had a known recent exposure to an individual affected with COVID-19 and:

  • who are immunocompromised and are unlikely to mount an adequate immune response to vaccination; or
  • for whom COVID-19 vaccination is not recommended.

If Evusheld™ is being considered it should be on a case-by-case basis where the potential benefit is expected to outweigh any potential risk, officials say.  There is strict criteria for eligibility; and residents are advised consult a prescriber (physician or nurse practitioner) to discuss whether this is an option.

Full eligibility details are available at Saskatchewan.ca/covid19-treatments.